1. Moosavi RA, Fong KC, Chopdar A. Retinal artery macroaneurysms: clinical and fluorescein angiographic features in 34 patients. Eye (Lond). 2006; 20:1011–1020.
Article
2. Pitkänen L, Tommila P, Kaarniranta K, et al. Retinal arterial macroaneurysms. Acta Ophthalmol. 2014; 92:101–104.
Article
3. Lavin MJ, Marsh RJ, Peart S, Rehman A. Retinal arterial macroaneurysms: a retrospective study of 40 patients. Br J Ophthalmol. 1987; 71:817–825.
Article
4. Kim DH, Yu HG. Clinical results of vitrectomy in macular hemorrhage from a ruptured retinal artery macroaneurysm. J Korean Ophthalmol Soc. 2010; 51:961–966.
Article
5. Moon SJ, Kim SW, Kim HS, et al. Intravitreal bevacizumab for macular edema secondary to ruptured retinal arterial macroaneurysm. J Korean Ophthalmol Soc. 2012; 53:522–527.
Article
6. Ohno-Matsui K, Hayano M, Futagami S, et al. Spontaneous involution of a large retinal arterial macroaneurysm. Acta Ophthalmol Scand. 2000; 78:114–117.
Article
7. Xu L, Wang Y, Jonas JB. Frequency of retinal macroaneurysms in adult Chinese: the Beijing Eye Study. Br J Ophthalmol. 2007; 91:840–841.
Article
8. Brown DM, Sobol WM, Folk JC, Weingeist TA. Retinal arteriolar macroaneurysms: long-term visual outcome. Br J Ophthalmol. 1994; 78:534–538.
Article
9. Tsujikawa A, Sakamoto A, Ota M, et al. Retinal structural changes associated with retinal arterial macroaneurysm examined with optical coherence tomography. Retina. 2009; 29:782–792.
Article
10. Pichi F, Morara M, Torrazza C, et al. Intravitreal bevacizumab for macular complications from retinal arterial macroaneurysms. Am J Ophthalmol. 2013; 155:287–294.e1.
Article
11. Battaglia Parodi M, Iacono P, Pierro L, et al. Subthreshold laser treatment versus threshold laser treatment for symptomatic retinal arterial macroaneurysm. Invest Ophthalmol Vis Sci. 2012; 53:1783–1786.
Article
12. Parodi MB, Iacono P, Ravalico G, Bandello F. Subthreshold laser treatment for retinal arterial macroaneurysm. Br J Ophthalmol. 2011; 95:534–538.
Article
13. Cho HJ, Rhee TK, Kim HS, et al. Intravitreal bevacizumab for symptomatic retinal arterial macroaneurysm. Am J Ophthalmol. 2013; 155:898–904.
Article
14. Mansour AM, Foster RE, Gallego-Pinazo R, et al. Intravitreal anti-vascular endothelial growth factor injections for exudative retinal arterial macroaneurysms. Retina. 2018; 03. 02. DOI:
10.1097/IAE.0000000000002131. [Epub ahead of print].
Article
15. Chanana B, Azad RV. Intravitreal bevacizumab for macular edema secondary to retinal macroaneurysm. Eye (Lond). 2009; 23:493–494.
Article
16. Zweifel SA, Tönz MS, Pfenninger L, et al. Intravitreal anti-VEGF therapy for retinal macroaneurysm. Klin Monbl Augenheilkd. 2013; 230:392–395.
Article
17. Cho HJ, Koh KM, Kim JH, et al. Intravitreal ranibizumab injections with and without pneumatic displacement for treating submacular hemorrhage secondary to neovascular age-related macular degeneration. Retina. 2015; 35:205–212.
Article